Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
The French National Humanitarian Conference
02/23/2016. What will be the role of international humanitarian actors in the aid system of the future?
Ethics and state funding: the quest for independent humanitarian action
02/22/2017. The ethical analysis of state funding is designed to ensure the independence of humanitarian action. In situations of armed conflict, it must be dynamic and adapted to the context.
“The generosity is huge but it has never been so insufficient”
The Vice-President of the European Commission, Kristalina Georgieva calls to reform the humanitarian aid system.
